HRP20040366B1 - Nova bakterijska bolest peradi - Google Patents

Nova bakterijska bolest peradi

Info

Publication number
HRP20040366B1
HRP20040366B1 HRP20040366AA HRP20040366A HRP20040366B1 HR P20040366 B1 HRP20040366 B1 HR P20040366B1 HR P20040366A A HRP20040366A A HR P20040366AA HR P20040366 A HRP20040366 A HR P20040366A HR P20040366 B1 HRP20040366 B1 HR P20040366B1
Authority
HR
Croatia
Prior art keywords
positive
negative
bacterium
beta
bacterial disease
Prior art date
Application number
HRP20040366AA
Other languages
English (en)
Croatian (hr)
Inventor
Elena Vazquez Maria
Campogarrido Raul
Gonzales-Hernandez Carlos
Sivanandan Vaithianathan
Original Assignee
Boehringer Ingelheim Vetmedica S.A. De C.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica S.A. De C.V. filed Critical Boehringer Ingelheim Vetmedica S.A. De C.V.
Publication of HRP20040366A2 publication Critical patent/HRP20040366A2/xx
Publication of HRP20040366B1 publication Critical patent/HRP20040366B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
HRP20040366AA 2001-10-26 2002-10-24 Nova bakterijska bolest peradi HRP20040366B1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10152307A DE10152307A1 (de) 2001-10-26 2001-10-26 Neue bakterielle Geflügelkrankheit
PCT/EP2002/011899 WO2003037367A2 (en) 2001-10-26 2002-10-24 New bacterium causing poultry disease and vaccine derived thereof

Publications (2)

Publication Number Publication Date
HRP20040366A2 HRP20040366A2 (en) 2005-04-30
HRP20040366B1 true HRP20040366B1 (hr) 2012-05-31

Family

ID=7703460

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20040366AA HRP20040366B1 (hr) 2001-10-26 2002-10-24 Nova bakterijska bolest peradi

Country Status (31)

Country Link
US (3) US7794735B2 (da)
EP (2) EP1942181A1 (da)
JP (2) JP4447319B2 (da)
KR (2) KR101024887B1 (da)
CN (1) CN100471945C (da)
AR (3) AR037020A1 (da)
AT (1) ATE391767T1 (da)
AU (1) AU2002363173B2 (da)
BR (1) BR0213538A (da)
CA (1) CA2462652A1 (da)
CO (1) CO5580796A2 (da)
CY (1) CY1108178T1 (da)
DE (2) DE10152307A1 (da)
DK (1) DK1442114T3 (da)
EC (1) ECSP045083A (da)
ES (1) ES2304466T3 (da)
HR (1) HRP20040366B1 (da)
HU (1) HU228692B1 (da)
IL (1) IL161223A0 (da)
MA (1) MA26293A1 (da)
MX (1) MXPA04003941A (da)
MY (1) MY138203A (da)
NO (1) NO333635B1 (da)
NZ (1) NZ532805A (da)
PL (1) PL206589B1 (da)
PT (1) PT1442114E (da)
RU (4) RU2334792C2 (da)
SI (1) SI1442114T1 (da)
UA (2) UA96948C2 (da)
WO (1) WO2003037367A2 (da)
ZA (1) ZA200402499B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10152307A1 (de) * 2001-10-26 2003-05-08 Boehringer Ingelheim Vetmed Neue bakterielle Geflügelkrankheit
CN102781954A (zh) * 2009-10-09 2012-11-14 哥本哈根大学 来自鸡卡氏杆菌的细胞溶解性rtx-毒素
CN102380092A (zh) * 2011-11-22 2012-03-21 青岛易邦生物工程有限公司 一种鸡传染性鼻炎灭活疫苗
CN102406936A (zh) * 2011-11-22 2012-04-11 青岛易邦生物工程有限公司 一种鸡传染性鼻炎灭活疫苗佐剂
AU2014234452B2 (en) 2013-03-18 2018-02-22 Intervet International B.V. Vaccine to protect a ruminant against pneumonia caused by Mannheimia haemolytica
RU2563885C1 (ru) * 2014-06-03 2015-09-27 Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) Способ определения антител к бактериальным антигенам
CN104491856A (zh) * 2014-12-07 2015-04-08 青岛易邦生物工程有限公司 一种禽肺病毒病灭活疫苗的生产方法
CN108728558A (zh) * 2018-05-31 2018-11-02 广西壮族自治区兽医研究所 一种快速检测溶血性曼氏杆菌的pcr扩增引物及其应用
CN111621450B (zh) * 2020-07-10 2022-07-05 青岛易邦生物工程有限公司 一种鸭源鸡杆菌及其应用
CN120060520B (zh) * 2025-04-03 2026-02-03 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 一种检测海藻糖比伯斯坦杆菌的引物对和试剂盒

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0865791A1 (fr) * 1997-03-17 1998-09-23 Vetoquinol S.A. Utilisation d'une souche de Pasteurella haemolytica sérotype A6 pour la préparation d'un vaccin contre la pasteurellose bovine due à Pasteurella haemolytica
US5849305A (en) * 1993-12-06 1998-12-15 The United States Of America As Represented By The Secretary Of The Department Of Agriculture Construction of Pasteurella haemolytica vaccines
US5855894A (en) * 1992-03-30 1999-01-05 Pfizer Inc. Pasteurella haemolytica type A-1 bacterin-toxoid vaccine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2051970C1 (ru) * 1992-06-24 1996-01-10 Северо-Кавказский зональный научно-исследовательский ветеринарный институт Способ выявления бактерий pasteurella multocida при пастереллезном процессе у птиц
ZA937652B (en) 1992-10-14 1994-05-04 Akzo Nv New bacterium causing poultry disease and vaccine derived thereof
RU2103355C1 (ru) * 1995-11-23 1998-01-27 Государственное Федеральное предприятие Государственный научный центр прикладной микробиологии Способ получения аттенуированных иммуногенных штаммов pasteurella multocida
CN1245058A (zh) * 1998-08-18 2000-02-23 曾泳铭 一种兽用抗病毒组合物
US7304151B2 (en) * 1999-12-17 2007-12-04 University Of Guelph Modified leukotoxin gene and protein
US7521060B2 (en) 2001-10-26 2009-04-21 Boehringer Ingelheim Vetmedica S.A. De C.V. Pathogen for bacterial poultry disease
DE10152307A1 (de) 2001-10-26 2003-05-08 Boehringer Ingelheim Vetmed Neue bakterielle Geflügelkrankheit

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5855894A (en) * 1992-03-30 1999-01-05 Pfizer Inc. Pasteurella haemolytica type A-1 bacterin-toxoid vaccine
US5849305A (en) * 1993-12-06 1998-12-15 The United States Of America As Represented By The Secretary Of The Department Of Agriculture Construction of Pasteurella haemolytica vaccines
EP0865791A1 (fr) * 1997-03-17 1998-09-23 Vetoquinol S.A. Utilisation d'une souche de Pasteurella haemolytica sérotype A6 pour la préparation d'un vaccin contre la pasteurellose bovine due à Pasteurella haemolytica

Also Published As

Publication number Publication date
US20090181055A1 (en) 2009-07-16
ZA200402499B (en) 2005-06-08
NZ532805A (en) 2008-04-30
US20100104594A1 (en) 2010-04-29
MXPA04003941A (es) 2004-11-29
JP4447319B2 (ja) 2010-04-07
DE60226057T2 (de) 2009-05-14
PT1442114E (pt) 2008-05-20
WO2003037367A2 (en) 2003-05-08
PL369963A1 (en) 2005-05-02
UA96948C2 (ru) 2011-12-26
EP1942181A1 (en) 2008-07-09
DE60226057D1 (de) 2008-05-21
HRP20040366A2 (en) 2005-04-30
UA89607C2 (ru) 2010-02-25
NO333635B1 (no) 2013-07-29
NO20041675L (no) 2004-04-23
AU2002363173B2 (en) 2007-09-20
MA26293A1 (fr) 2004-09-01
CN100471945C (zh) 2009-03-25
KR20090083941A (ko) 2009-08-04
RU2007129099A (ru) 2009-02-10
CO5580796A2 (es) 2005-11-30
JP5087604B2 (ja) 2012-12-05
RU2007148219A (ru) 2009-07-10
ES2304466T3 (es) 2008-10-16
AR037020A1 (es) 2004-10-20
MY138203A (en) 2009-05-29
AR067732A2 (es) 2009-10-21
CA2462652A1 (en) 2003-05-08
RU2456343C2 (ru) 2012-07-20
RU2430967C2 (ru) 2011-10-10
HUP0402098A3 (en) 2005-07-28
US20110212132A1 (en) 2011-09-01
JP2010051324A (ja) 2010-03-11
CN1575334A (zh) 2005-02-02
RU2004116134A (ru) 2005-05-10
CY1108178T1 (el) 2014-02-12
HU228692B1 (en) 2013-05-28
ATE391767T1 (de) 2008-04-15
ECSP045083A (es) 2004-08-27
EP1442114B1 (en) 2008-04-09
BR0213538A (pt) 2004-10-19
DE10152307A1 (de) 2003-05-08
PL206589B1 (pl) 2010-08-31
RU2334792C2 (ru) 2008-09-27
HUP0402098A2 (hu) 2005-02-28
US7964197B2 (en) 2011-06-21
SI1442114T1 (sl) 2008-08-31
AR073482A2 (es) 2010-11-10
RU2481393C2 (ru) 2013-05-10
DK1442114T3 (da) 2008-06-09
JP2005511032A (ja) 2005-04-28
US7794735B2 (en) 2010-09-14
WO2003037367A3 (en) 2003-10-09
HK1073862A1 (zh) 2005-10-21
KR100954175B1 (ko) 2010-04-20
RU2008136404A (ru) 2010-03-20
EP1442114A2 (en) 2004-08-04
KR101024887B1 (ko) 2011-03-31
KR20050039688A (ko) 2005-04-29
IL161223A0 (en) 2004-09-27

Similar Documents

Publication Publication Date Title
Upreti et al. Isolation and characterization of a bacteriocin from a homofermentative Lactobacillus
HRP20040366B1 (hr) Nova bakterijska bolest peradi
Sebunya et al. Haemophilus pleuropneumoniae infection in swine: a review
ATE333285T1 (de) Attenuierte salmonella mutanten, welche das vi- antigen konstant exprimieren
ATE299712T1 (de) Stabilisatoren für lebendimpfstoffe
NO912603L (no) Polymer-blanding.
ES538984A0 (es) Procedimiento para la obtencion de un insecticida bacteriano
FI843716A7 (fi) Pyridiiniliukoista uutetta ja puhdistettua, myrkyttömäksi tehtyä endotoksiinia sisältävä koostumus ja sen käyttö.
ATE295720T1 (de) Impfstoff für geflügel
Jonas et al. Characterization of nine Pasteurella multocida isolates from avian cholera outbreaks in Indonesia
IT8120393A0 (it) Mutanti batterici, procedimento per produrli e vaccini vivi che licontengono.
BE894762A (fr) Agents antibacteriens ll-c23024beta et iota, leur procede de preparation et microorganisme, actionomadura yumaense nrrl 12515
NO890366D0 (no) Antistoff-bindende seter som utviser stereoselektiv synthase-aktivitet, og metoder under anvendelse av samme.
ES8302086A1 (es) Un procedimiento para preparar vacunas de pasteurella multocida y pasteunella haemolytica vivas modificadas con efectos veterinarios, particularmente para especies de animales bovinos, porcinos y ovinos.
FI864795A0 (fi) Komposition innehaollande primicin.
SE7904161L (sv) Komposition for minskning av fenylalaninnivan i blod och anvendning derav
JPS53119900A (en) Preparation of aqueous solution of high viscosity and high molecular weight keratin
IL85761A (en) Broadband,high speed video amplifier
ES463092A1 (es) Procedimiento de obtencion de los compuestos 8-(1h-tetrazol-5-il)-11h pirido (2,1-b) quinazolin-11-onas, y las sales farmaceuticamente aceptables de acidos y bases de los mis- mos.
Shulman MOVIE I PLAY REVIEW
DK572885A (da) Extracellulaert polysaccharid, fremgangsmaade og bakteriestamme til dets anvendelse
ES457496A1 (es) Procedimiento para la obtencion de una composicion pulveru- lenta e hidrosoluble de sulfamidina y pirimetamina.
ES8307828A1 (es) Procedimiento para la preparacion de tiazolo-y (1,3)tiazino-(2,3-c) (1,2,4) triazinonas con efecto herbicida selectivo.
Grosskopf et al. Contribution of beta circuit completion towards virulence factor stability and function
HUI et al. The isolation of a flocculant-producing bacillus and identification of microbial flocculant

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20120926

Year of fee payment: 11

PBON Lapse due to non-payment of renewal fee

Effective date: 20131024